2019
DOI: 10.1016/j.prp.2019.152556
|View full text |Cite
|
Sign up to set email alerts
|

Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
107
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 221 publications
(108 citation statements)
references
References 64 publications
1
107
0
Order By: Relevance
“…As a result, that mediation of IL-6 and soluble IL-6 receptor secretion by the miR-145-ADAM17 pathway has been revealed that could played a role in maintaining the CSC characteristics in a paracrine way. Curcumin is a natural compounds that could be used in the treatment of different diseases such as cancer [168][169][170][171][172][173][174][175]. The curcumin delivery attenuated the tumor expansion in vivo by enhancing the miR-145 promoter activities [167].…”
Section: Micrornasmentioning
confidence: 99%
“…As a result, that mediation of IL-6 and soluble IL-6 receptor secretion by the miR-145-ADAM17 pathway has been revealed that could played a role in maintaining the CSC characteristics in a paracrine way. Curcumin is a natural compounds that could be used in the treatment of different diseases such as cancer [168][169][170][171][172][173][174][175]. The curcumin delivery attenuated the tumor expansion in vivo by enhancing the miR-145 promoter activities [167].…”
Section: Micrornasmentioning
confidence: 99%
“…Cervical cancer is known as the fourth cancer among women and the eighth common cancer worldwide [1,2]. Cervical cancer is a result of being infected by some types of human papillomavirus or HPV, which are effective on the mucosa [3,4].…”
Section: Introductionmentioning
confidence: 99%
“…1,2 Although CC at the early stage could be cured via surgery, most patients are diagnosed at advanced or metastatic stages. 3,4 Treatment by surgery, chemotherapy and radiotherapy achieves unsatisfactory outcomes in these advanced patients. And the five-year survival rate of CC patients remains very low.…”
Section: Introductionmentioning
confidence: 99%